Topic:

Biomarkers

Latest Headlines

Latest Headlines

Boston startup gets $4M Series B to develop point-of-care TBI biomarker test

Boston-based BioDirection has raised a $4 million Series B round to back its point-of-care traumatic brain injury test Tbit. The financing is expected to enable the startup to finalize development and to start commercial planning for the test.

Philips partners with San Diego startup to develop hand-held concussion blood test

Royal Philips has struck a deal with Banyan Biomarkers to develop and sell a new hand-held blood test that can be used to detect mild traumatic brain injury, more commonly known as concussion, at the point of care.

MDxHealth's $8.8M acquisition of NovioGendix is a liquid biopsy play

MDxHealth announced that it is buying the Netherlands' NovioGendix for up to $8.8 million to get its hands on liquid biopsy technology for diagnosing prostate cancer, as interest grows in the burgeoning arena of uro-oncology.

MDxHealth's $8.8M acquisition of NovioGendix is a liquid biopsy play

MDxHealth announced that it is buying the Netherlands' NovioGendix for up to $8.8 million to get its hands on liquid biopsy technology for diagnosing prostate cancer, as interest grows in the burgeoning arena of uro-oncology.

Biocept partners with UC Irvine on liquid biopsy research

Liquid biopsy player Biocept is teaming up with the University of California, Irvine, to evaluate blood-based biomarkers (as opposed to tissue-based ones) in patients with metastatic cancers. The duo hopes to validate liquid biopsies as a treatment guide for precision medicines and develop a system for monitoring tumor mutations to identify signs of resistance to therapy.

Biocept partners with UC Irvine on liquid biopsy research

Liquid biopsy player Biocept is teaming up with the University of California, Irvine, to evaluate blood-based biomarkers (as opposed to tissue-based ones) in patients with metastatic cancers. The duo hopes to validate liquid biopsies as a treatment guide for precision medicines and develop a system for monitoring tumor mutations to identify signs of resistance to therapy.

NIH study finds blood biomarker for traumatic brain injury using sensitive analyzer

An article in the Journal of the American Medical Association concluded that the concentration of tau protein in the bloodstream is correlated with traumatic brain injury, after assessing nearly 100 U.S. soldiers who had been deployed to Iraq and Afghanistan.

NIH study finds blood biomarker for traumatic brain injury using sensitive analyzer

An article in the Journal of the American Medical Association concluded that the concentration of tau protein in the bloodstream is correlated with traumatic brain injury, after assessing nearly 100 U.S. soldiers who had been deployed to Iraq and Afghanistan.

NIH provides $28M to study autism biomarkers via its Biomarkers Consortium

The National Institutes of Health is providing $28 million over the next four years to fund research into autism biomarkers, such as eye tracking, automated recordings of behavior and speech, and measures of brain activity via electroencephalogram under its public-private Biomarkers Consortium.

NIH provides $28M to study autism biomarkers via its Biomarkers Consortium

The National Institutes of Health is providing $28 million over the next four years to fund research into autism biomarkers, such as eye tracking, automated recordings of behavior and speech, and measures of brain activity via electroencephalogram under its public-private Biomarkers Consortium.